Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
This study is ongoing, but not recruiting participants.
Study NCT01317927   Information provided by Spectrum Pharmaceuticals, Inc

First Received on March 9, 2011.   Last Updated on May 8, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Tumor
Hematological Malignancy
Additional conditions recognized in this trial
Hematologic Neoplasms
Neoplasms
More general conditions related to this trial
Hematologic Diseases
Neoplasms by Site
Interventions listed in this trial
Belinostat, Warfarin
Additional drug interventions recognized in this trial
Warfarin
More general drug interventions related to this trial
Anticoagulants
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Spectrum Pharmaceuticals, Inc
TopoTarget A/S


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services